Search
Search Results
##search.searchResults.foundPlural##
-
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3583PDF: 1205HTML: 5005Incidence age-standardized rates for HL across the Mediterranean basin: 209 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2610PDF: 756HTML: 2312 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2477PDF: 1248HTML: 3609Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 414 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3359PDF: 1329HTML: 6200 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4837PDF: 1795HTML: 2723Untitled: 227 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4294PDF: 1533HTML: 459 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4006Suppl. Files: 1140PDF: 1087Html: 180 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3067PDF: 918HTML: 2042 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3303PDF: 950HTML: 2965 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1417PDF: 1326HTML: 101 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3205PDF: 1853HTML: 3672 -
-
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2656PDF: 963HTML: 3645 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2798PDF: 1132HTML: 3294 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2249PDF: 1056HTML: 1989Characteristic of study group: 206 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1261PDF: 650HTML: 7734 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7070PDF: 3986HTML: 24894 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2042PDF: 768HTML: 3117 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4793PDF: 1568HTML: 2251Untitled: 217Untitled: 233Untitled: 237Untitled: 223Untitled: 224 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3657PDF: 903HTML: 6722 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3942PDF: 1492HTML: 8520







